Status:
RECRUITING
Tunisian Lung Cancer Study
Lead Sponsor:
Dacima Consulting
Collaborating Sponsors:
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
Tunisian Society of Respiratory Diseases and Allergology
Conditions:
Pulmonary Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, t...
Eligibility Criteria
Inclusion
- Age more than 18 years
- Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
- Informed consent
Exclusion
- None
Key Trial Info
Start Date :
May 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
1334 Patients enrolled
Trial Details
Trial ID
NCT06934499
Start Date
May 2 2025
End Date
October 30 2026
Last Update
June 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tunisian Society of Medical Oncology
Aryanah, Tunisia, 2080
2
Tunisian Society of Respiratory Diseases and Allergology
Tunis, Tunisia